Wilfried Dinh

Wilfried Dinh, MD, MBA, FESC, currently serves as a Senior Program Leader at Boehringer Ingelheim since January 2024. Previously, Wilfried Dinh worked at Bayer Pharmaceuticals from August 2012 to January 2024 as an Early Clinical Leader in Translational Precision Medicine, where expertise in developing early clinical strategies and orchestrating clinical trials was established. Prior to Bayer, Wilfried Dinh practiced cardiology as a private practitioner in Wuppertal, and held various positions involving research and clinical trials within cardiology at institutions such as CoroVital and University of Witten/Herdecke. Earlier experience includes serving as an attending cardiologist at Helios Clinics Wuppertal and working in internal medicine at St. Martinus Hospital. Wilfried Dinh earned an MD from the University of Düsseldorf, an MBA from Gies College of Business - University of Illinois Urbana-Champaign, and a diploma in Tropical Medicine from the Bernard Nocht Institute in Hamburg.